Global Non-Invasive Prenatal DNA Testing Service Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI11243406

Publication Date:

November 8, 2024

Pages:

104

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The non-invasive prenatal DNA testing service collects peripheral venous blood from pregnant women, uses the next-generation DNA sequencing technology to sequence the free DNA fragments (including fetal free DNA) in the maternal peripheral plasma, and performs bioinformatics analysis on the sequencing results to obtain the genetic information of the fetus and detect whether the fetus has a chromosomal disease.
The global Non-Invasive Prenatal DNA Testing Service market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淣on-Invasive Prenatal DNA Testing Service Industry Forecast鈥� looks at past sales and reviews total world Non-Invasive Prenatal DNA Testing Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Non-Invasive Prenatal DNA Testing Service sales for 2023 through 2029. With Non-Invasive Prenatal DNA Testing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Invasive Prenatal DNA Testing Service industry.
This Insight Report provides a comprehensive analysis of the global Non-Invasive Prenatal DNA Testing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-Invasive Prenatal DNA Testing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Non-Invasive Prenatal DNA Testing Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Invasive Prenatal DNA Testing Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Invasive Prenatal DNA Testing Service.
United States market for Non-Invasive Prenatal DNA Testing Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Non-Invasive Prenatal DNA Testing Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Non-Invasive Prenatal DNA Testing Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Non-Invasive Prenatal DNA Testing Service players cover Natera Inc, Illumina, Roche, GE Healthcare, Thermo Fisher Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Invasive Prenatal DNA Testing Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Serum Biochemical Index Detection
Maternal Peripheral Blood Free DNA Detection
Ultrasound Screening
Segmentation by Application:
Hospitals
Medical Institutions
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Serum Biochemical Index Detection
Maternal Peripheral Blood Free DNA Detection
Ultrasound Screening
Segmentation by Application:
Hospitals
Medical Institutions
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Natera Inc
Illumina
Roche
GE Healthcare
Thermo Fisher Scientific
Perkinelmer
Qiagen
Agilent Technologies
Veritas
BGI Group
Annoroad

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-Invasive Prenatal DNA Testing Service Market Size 2019-2030
2.1.2 Non-Invasive Prenatal DNA Testing Service Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Non-Invasive Prenatal DNA Testing Service by Country/Region, 2019, 2023 & 2030
2.2 Non-Invasive Prenatal DNA Testing Service Segment by Type
2.2.1 Serum Biochemical Index Detection
2.2.2 Maternal Peripheral Blood Free DNA Detection
2.2.3 Ultrasound Screening
2.3 Non-Invasive Prenatal DNA Testing Service Market Size by Type
2.3.1 Non-Invasive Prenatal DNA Testing Service Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Non-Invasive Prenatal DNA Testing Service Market Size Market Share by Type (2019-2024)
2.4 Non-Invasive Prenatal DNA Testing Service Segment by Application
2.4.1 Hospitals
2.4.2 Medical Institutions
2.4.3 Others
2.5 Non-Invasive Prenatal DNA Testing Service Market Size by Application
2.5.1 Non-Invasive Prenatal DNA Testing Service Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Non-Invasive Prenatal DNA Testing Service Market Size Market Share by Application (2019-2024)
3 Non-Invasive Prenatal DNA Testing Service Market Size by Player
3.1 Non-Invasive Prenatal DNA Testing Service Market Size Market Share by Player
3.1.1 Global Non-Invasive Prenatal DNA Testing Service Revenue by Player (2019-2024)
3.1.2 Global Non-Invasive Prenatal DNA Testing Service Revenue Market Share by Player (2019-2024)
3.2 Global Non-Invasive Prenatal DNA Testing Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Non-Invasive Prenatal DNA Testing Service by Region
4.1 Non-Invasive Prenatal DNA Testing Service Market Size by Region (2019-2024)
4.2 Global Non-Invasive Prenatal DNA Testing Service Annual Revenue by Country/Region (2019-2024)
4.3 Americas Non-Invasive Prenatal DNA Testing Service Market Size Growth (2019-2024)
4.4 APAC Non-Invasive Prenatal DNA Testing Service Market Size Growth (2019-2024)
4.5 Europe Non-Invasive Prenatal DNA Testing Service Market Size Growth (2019-2024)
4.6 Middle East & Africa Non-Invasive Prenatal DNA Testing Service Market Size Growth (2019-2024)
5 Americas
5.1 Americas Non-Invasive Prenatal DNA Testing Service Market Size by Country (2019-2024)
5.2 Americas Non-Invasive Prenatal DNA Testing Service Market Size by Type (2019-2024)
5.3 Americas Non-Invasive Prenatal DNA Testing Service Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Invasive Prenatal DNA Testing Service Market Size by Region (2019-2024)
6.2 APAC Non-Invasive Prenatal DNA Testing Service Market Size by Type (2019-2024)
6.3 APAC Non-Invasive Prenatal DNA Testing Service Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Non-Invasive Prenatal DNA Testing Service Market Size by Country (2019-2024)
7.2 Europe Non-Invasive Prenatal DNA Testing Service Market Size by Type (2019-2024)
7.3 Europe Non-Invasive Prenatal DNA Testing Service Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-Invasive Prenatal DNA Testing Service by Region (2019-2024)
8.2 Middle East & Africa Non-Invasive Prenatal DNA Testing Service Market Size by Type (2019-2024)
8.3 Middle East & Africa Non-Invasive Prenatal DNA Testing Service Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Non-Invasive Prenatal DNA Testing Service Market Forecast
10.1 Global Non-Invasive Prenatal DNA Testing Service Forecast by Region (2025-2030)
10.1.1 Global Non-Invasive Prenatal DNA Testing Service Forecast by Region (2025-2030)
10.1.2 Americas Non-Invasive Prenatal DNA Testing Service Forecast
10.1.3 APAC Non-Invasive Prenatal DNA Testing Service Forecast
10.1.4 Europe Non-Invasive Prenatal DNA Testing Service Forecast
10.1.5 Middle East & Africa Non-Invasive Prenatal DNA Testing Service Forecast
10.2 Americas Non-Invasive Prenatal DNA Testing Service Forecast by Country (2025-2030)
10.2.1 United States Market Non-Invasive Prenatal DNA Testing Service Forecast
10.2.2 Canada Market Non-Invasive Prenatal DNA Testing Service Forecast
10.2.3 Mexico Market Non-Invasive Prenatal DNA Testing Service Forecast
10.2.4 Brazil Market Non-Invasive Prenatal DNA Testing Service Forecast
10.3 APAC Non-Invasive Prenatal DNA Testing Service Forecast by Region (2025-2030)
10.3.1 China Non-Invasive Prenatal DNA Testing Service Market Forecast
10.3.2 Japan Market Non-Invasive Prenatal DNA Testing Service Forecast
10.3.3 Korea Market Non-Invasive Prenatal DNA Testing Service Forecast
10.3.4 Southeast Asia Market Non-Invasive Prenatal DNA Testing Service Forecast
10.3.5 India Market Non-Invasive Prenatal DNA Testing Service Forecast
10.3.6 Australia Market Non-Invasive Prenatal DNA Testing Service Forecast
10.4 Europe Non-Invasive Prenatal DNA Testing Service Forecast by Country (2025-2030)
10.4.1 Germany Market Non-Invasive Prenatal DNA Testing Service Forecast
10.4.2 France Market Non-Invasive Prenatal DNA Testing Service Forecast
10.4.3 UK Market Non-Invasive Prenatal DNA Testing Service Forecast
10.4.4 Italy Market Non-Invasive Prenatal DNA Testing Service Forecast
10.4.5 Russia Market Non-Invasive Prenatal DNA Testing Service Forecast
10.5 Middle East & Africa Non-Invasive Prenatal DNA Testing Service Forecast by Region (2025-2030)
10.5.1 Egypt Market Non-Invasive Prenatal DNA Testing Service Forecast
10.5.2 South Africa Market Non-Invasive Prenatal DNA Testing Service Forecast
10.5.3 Israel Market Non-Invasive Prenatal DNA Testing Service Forecast
10.5.4 Turkey Market Non-Invasive Prenatal DNA Testing Service Forecast
10.6 Global Non-Invasive Prenatal DNA Testing Service Forecast by Type (2025-2030)
10.7 Global Non-Invasive Prenatal DNA Testing Service Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Non-Invasive Prenatal DNA Testing Service Forecast
11 Key Players Analysis
11.1 Natera Inc
11.1.1 Natera Inc Company Information
11.1.2 Natera Inc Non-Invasive Prenatal DNA Testing Service Product Offered
11.1.3 Natera Inc Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Natera Inc Main Business Overview
11.1.5 Natera Inc Latest Developments
11.2 Illumina
11.2.1 Illumina Company Information
11.2.2 Illumina Non-Invasive Prenatal DNA Testing Service Product Offered
11.2.3 Illumina Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Illumina Main Business Overview
11.2.5 Illumina Latest Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Non-Invasive Prenatal DNA Testing Service Product Offered
11.3.3 Roche Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Roche Main Business Overview
11.3.5 Roche Latest Developments
11.4 GE Healthcare
11.4.1 GE Healthcare Company Information
11.4.2 GE Healthcare Non-Invasive Prenatal DNA Testing Service Product Offered
11.4.3 GE Healthcare Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 GE Healthcare Main Business Overview
11.4.5 GE Healthcare Latest Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Information
11.5.2 Thermo Fisher Scientific Non-Invasive Prenatal DNA Testing Service Product Offered
11.5.3 Thermo Fisher Scientific Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Thermo Fisher Scientific Main Business Overview
11.5.5 Thermo Fisher Scientific Latest Developments
11.6 Perkinelmer
11.6.1 Perkinelmer Company Information
11.6.2 Perkinelmer Non-Invasive Prenatal DNA Testing Service Product Offered
11.6.3 Perkinelmer Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Perkinelmer Main Business Overview
11.6.5 Perkinelmer Latest Developments
11.7 Qiagen
11.7.1 Qiagen Company Information
11.7.2 Qiagen Non-Invasive Prenatal DNA Testing Service Product Offered
11.7.3 Qiagen Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Qiagen Main Business Overview
11.7.5 Qiagen Latest Developments
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Information
11.8.2 Agilent Technologies Non-Invasive Prenatal DNA Testing Service Product Offered
11.8.3 Agilent Technologies Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Agilent Technologies Main Business Overview
11.8.5 Agilent Technologies Latest Developments
11.9 Veritas
11.9.1 Veritas Company Information
11.9.2 Veritas Non-Invasive Prenatal DNA Testing Service Product Offered
11.9.3 Veritas Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Veritas Main Business Overview
11.9.5 Veritas Latest Developments
11.10 BGI Group
11.10.1 BGI Group Company Information
11.10.2 BGI Group Non-Invasive Prenatal DNA Testing Service Product Offered
11.10.3 BGI Group Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 BGI Group Main Business Overview
11.10.5 BGI Group Latest Developments
11.11 Annoroad
11.11.1 Annoroad Company Information
11.11.2 Annoroad Non-Invasive Prenatal DNA Testing Service Product Offered
11.11.3 Annoroad Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Annoroad Main Business Overview
11.11.5 Annoroad Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂